« Return to News | Awards & Advancement

PAREXEL appoints Larson as VP of evidence development

Friday, August 3, 2012 12:25 PM

PAREXEL Consulting, a business unit of PAREXEL International and a global consultancy serving the biopharmaceutical and medical device industries, has appointed Leanne R. Larson as vice president of evidence development, a newly created position.

Larson brings 25 years of experience in healthcare to PAREXEL, including extensive work in pharmaceutical product development, marketing, healthcare technology and operational consulting. Prior to joining PAREXEL, she served more than 15 years in senior and strategic roles within Clinical Research Organizations. Larson has also held positions in Ernst & Young's Life Sciences and Pharmaceuticals consulting practice, as well as at Merck's Health Sciences-Digestive Disease group.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

May 20

IRB consolidation trend continues, as private equity firm Audax buys majority stake in Chesapeake

Quintiles, Merck Serono ink exclusive partnership

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

INC Research, PPD, inVentiv named top CROs
Yet most CROs slipping in ability to manage site relationships

R&D cuts by sponsors spur more collaboration, innovation
New strategies share pipeline activity costs

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

20 innovators changing the face of the clinical trials industry
The CenterWatch Monthly honors individuals, teams and companies for their forward-thinking ideas and their ability to implement them.

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.